New approach for high-throughput screening of drug activity on Plasmodium liver stages.
about
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domainRecent advances in malaria drug discoveryVisualisation and quantitative analysis of the rodent malaria liver stage by real time imagingImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryA plant-derived morphinan as a novel lead compound active against malaria liver stagesThe next opportunity in anti-malaria drug discovery: the liver stageInhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinationsKAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.Characterization of Plasmodium liver stage inhibition by halofuginone.Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionImaging flow cytometry analysis of intracellular pathogens.CRIMALDDI: platform technologies and novel anti-malarial drug targets.Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro.Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.Challenges in antimalarial drug discovery.Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry.Phenotypic Screens in Antimalarial Drug Discovery.Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review.Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.Screening for potential prophylactics targeting sporozoite motility through the skin
P2860
Q21090524-6AFAED66-1055-41A4-96A4-0E68A8CECB57Q27010534-D667BD24-E7C3-49EB-A02B-67A245AB72F4Q27335248-85168853-AA14-44F9-9DF8-976EA2E0F127Q27861956-3BF783D2-0A26-405A-AD9B-B33422E3C27BQ28469086-3BC16876-0383-492F-9ECB-E0307C60A983Q28477177-A20E84A8-45B2-4E42-B56F-11FD380732A5Q28742222-E9679BEC-D2E5-4DF3-B485-8A9375A759FBQ34057433-CA4574FE-29AE-430F-A667-A648C6CDD706Q35983791-5AF574FF-9FBC-4D88-A3D5-AA97042E6945Q36004060-A9007BB3-187D-46BA-8090-A4684252078FQ36136833-4A27AD6C-556B-4568-A66B-566C65556799Q37308061-8AD10FCF-7F4A-4E09-BFC5-55714820E9DBQ37566109-C0D369F2-CBB5-4912-9A6A-E54C6CD5E463Q37694755-C70D5CC8-D668-43CB-98A4-9AFBE19D74F4Q37924296-A36496DF-919E-4A8A-A392-C244D7CDD704Q38261775-5E737641-F809-4DFD-8FAC-C33C0BF746CCQ38849773-22F1EFEF-AD38-4B61-B05A-E86D4A4E7729Q45770576-31F1A6C0-1502-45FC-9311-AF7BCD546171Q46322657-4C9E19C6-499C-420C-9D0D-D32AB271655FQ58781866-D43F8226-A2DF-4745-9E15-52800B83AEFA
P2860
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@en
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@nl
type
label
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@en
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@nl
prefLabel
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@en
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@nl
P2093
P2860
P50
P1476
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
@en
P2093
Adrian J F Luty
Audrey Gego
Dominique Mazier
Khemaïs Farhati
P2860
P304
P356
10.1128/AAC.50.4.1586-1589.2006
P407
P50
P577
2006-04-01T00:00:00Z